Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Testis-specific protein 10-interacting protein (TSGA10IP) is a protein-coding gene expressed notably in the testis and predicted to be active in the photoreceptor connecting cilium, with a potential role in cilium organization. The protein has no confirmed association with any therapeutic drug, and there is currently no evidence suggesting it is a conventional therapeutic target (such as a receptor or enzyme). TSGA10IP is conserved in humans and mice, with sequence information curated under various genetic and protein databases. Its precise physiological function is not well established, though molecular evidence implicates it in cellular structural roles relating to cilia and potentially spermatogenesis. There is no direct evidence that TSGA10IP is implicated in disease mechanisms or therapeutic safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis-specific protein 10-interacting protein (TSGA10IP).